Alexandria, Va. – The American Society of Clinical Oncology (ASCO) and The ASCO Cancer Foundation are honoring 10 community oncology practices for their efforts to improve care of people with cancer through participation in clinical trials. The Clinical Trials Participation Awards will be presented Sunday, June 1, 2008 at ASCO’s 44th Annual Meeting in Chicago.
Alexandria, Va.- Next week marks the 20th anniversary of National Minority Cancer Awareness Week, established by Congress to bring attention to health disparities experienced by minority groups. The American Society of Clinical Oncology (ASCO) is developing tools and resources for improving access to care for people with cancer in underserved communities and increasing minority representation in the oncology workforce.
Alexandria, Va. —The American Society of Clinical Oncology (ASCO) has expanded its tools to improve documentation and coordination of cancer treatment and survivorship care by developing a “generic” chemotherapy treatment plan and summary template that can be customized for almost any cancer diagnosis.
ALEXANDRIA, Va. —The American Society of Clinical Oncology (ASCO) is collaborating with leading health plans to recognize oncologists who are actively involved in assessing and improving the quality of care provided to patients with cancer.
Alexandria, VA. – The American Society of Clinical Oncology (ASCO) supports Texas Proposition 15, which, if passed this Election Day on November 6, would authorize up to $3 billion in state general revenue bonds to fund cancer research, prevention, early detection, and control programs.
ALEXANDRIA, Va.— The American Society of Clinical Oncology (ASCO) released new clinical guideline recommendations on the use of anticoagulants to treat venous thromboembolism (VTE), or blood clot, in people with cancer.
ALEXANDRIA, Va. — The American Society of Clinical Oncology (ASCO) has updated its clinical practice guideline on the use of tumor markers in breast cancer.
ALEXANDRIA, Va.— The American Society of Clinical Oncology (ASCO) and Cancer Care of Ontario (CCO) issued a new collaborative clinical practice guideline on adjuvant therapy, or the use of chemotherapy or radiation after surgery, for treating non-small cell lung cancer (NSCLC).
WASHINGTON, D.C. – The American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH) have released an updated joint guideline on the use of erythropoiesis-stimulating agents (ESAs), a class of drugs that stimulate the bone marrow to produce more red blood cells, to treat chemotherapy-related anemia.
Alexandria, Va. – In a major victory for cancer care, the Centers for Medicare & Medicaid Services (CMS) stated yesterday that it would not change its clinical trials coverage policy.
